Montoya S, Bourcier J, Noviski M, Lu H, Thompson MC, Chirino A, Jahn J, Sondhi AK, Gajewski S, Tan YSM, Yung S, Urban A, Wang E, Han C, Mi X, Kim WJ, Sievers Q, Auger P, Bousquet H, Brathaban N, Bravo B, Gessner M, Guiducci C, Iuliano JN, Kane Tet al.(2024) Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127 Science, 383(6682), eadi5798 DOI 10.1126/science.adi5798, PubMed 38301010
Andersen AN, Brodersen AM, Ayuda-Durán P, Piechaczyk L, Tadele DS, Baken L, Fredriksen J, Stoksflod M, Lenartova A, Fløisand Y, Skånland SS, Enserink JM(2023) Clinical forecasting of acute myeloid leukemia using ex vivo drug-sensitivity profiling Cell Rep Methods, 3(12), 100654 DOI 10.1016/j.crmeth.2023.100654, PubMed 38065095
Ayuda-Durán P, Hermansen JU, Giliberto M, Yin Y, Hanes R, Gordon S, Kuusanmäki H, Brodersen AM, Andersen AN, Taskén K, Wennerberg K, Enserink JM, Skånland SS(2023) Standardized assays to monitor drug sensitivity in hematologic cancers Cell Death Discov, 9(1), 435 DOI 10.1038/s41420-023-01722-5, PubMed 38040674